|
Delayed
Nasdaq
15:48:27 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 4.730 USD | +0.42% |
|
-11.12% | -91.73% |
| 09-16 | Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma | FI |
| 09-15 | Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUTEP LIMITED | Other Biotechnology & Medical Research | +0.42% | -11.12% | -91.73% | -86.49% | -93.89% | 34.95M |  | | |
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
- Charts Immutep Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
